- Home
- CHR vs AGEN Comparison
CHR vs AGEN Comparison
Compare CHR & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHR | AGEN |
|---|---|---|
| Founded | 2016 | 1994 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.9M | 126.2M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | CHR | AGEN |
|---|---|---|
| Price | $1.06 | $3.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 72.8K | ★ 372.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $42,877,086.00 |
| Revenue This Year | N/A | $5.19 |
| Revenue Next Year | N/A | $68.25 |
| P/E Ratio | ★ $0.01 | $8.04 |
| Revenue Growth | N/A | ★ 89.95 |
| 52 Week Low | $0.03 | $1.38 |
| 52 Week High | $2.09 | $7.34 |
Technical Indicators
Market Signals| Indicator | CHR | AGEN |
|---|---|---|
| Relative Strength Index (RSI) | 33.10 | 56.73 |
| Support Level | $0.07 | $2.90 |
| Resistance Level | $1.56 | $4.72 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 0.91 | 75.01 |
Price Performance
Historical ComparisonAbout CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).